Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Improving Translational Accuracy02:07

Improving Translational Accuracy

Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
Improving Translational Accuracy02:07

Improving Translational Accuracy

Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of Circulating T Cell and Tumor Microenvironment Profiles with Immune Checkpoint Blockade Outcomes in Sarcoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Tumor and Immune Dynamics Following Sequential CDK4/6 and PD-1 Inhibition: Results from a Phase 2 Study in Dedifferentiated Liposarcoma.

Cancer research communications·2025
Same author

Histologic Subvariants of Retroperitoneal Well-Differentiated Liposarcoma Show Evidence of Clinical and Genomic Progression Toward Dedifferentiated Liposarcoma.

JCO precision oncology·2025
Same author

ctDNA as a Molecular Biomarker in the Phase II Trial of Imatinib plus Binimetinib in Patients with Advanced Gastrointestinal Stromal Tumor.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

Organ Preservation in Rectal Cancer: Fear of Risks Versus the Risks of Fear.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025
Same author

Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with Sarcoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2024
Same journal

STED: flexible cross-modal topic modeling infers cell-type-specific regulatory landscapes from bulk epigenomics.

Briefings in bioinformatics·2026
Same journal

A knowledge-guided deep learning framework for quantitative nucleic acid testing.

Briefings in bioinformatics·2026
Same journal

Optimal transport for label transfer in single-cell multi-omics integration.

Briefings in bioinformatics·2026
Same journal

Continuous multi-omics pathway enrichment analysis resolves hidden functional heterogeneity.

Briefings in bioinformatics·2026
Same journal

Evaluating completeness, coherence, and consistency of genome-scale function annotations.

Briefings in bioinformatics·2026
Same journal

Transformers for single-cell RNA sequencing: a survey.

Briefings in bioinformatics·2026
See all related articles

Related Experiment Video

Updated: Jun 12, 2026

Droplet Barcoding-Based Single Cell Transcriptomics of Adult Mammalian Tissues
10:12

Droplet Barcoding-Based Single Cell Transcriptomics of Adult Mammalian Tissues

Published on: January 10, 2019

18.4K

Optimizing sample size for supervised machine learning with bulk transcriptomic sequencing: a learning curve

Yunhui Qi1,2, Xinyi Wang1,3, Li-Xuan Qin1

  • 1Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 633 Third Avenue, New York, NY 10017, United States.

Briefings in Bioinformatics
|March 12, 2025
PubMed
Summary
This summary is machine-generated.

Determining the right sample size for transcriptomics studies is key for personalized medicine. This study introduces a novel computational method to establish the accuracy-sample size relationship, improving machine learning applications in healthcare.

Keywords:
bulk sequencingmachine learningsample sizetranscriptomics

More Related Videos

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets
06:40

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets

Published on: February 23, 2024

1.2K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

616

Related Experiment Videos

Last Updated: Jun 12, 2026

Droplet Barcoding-Based Single Cell Transcriptomics of Adult Mammalian Tissues
10:12

Droplet Barcoding-Based Single Cell Transcriptomics of Adult Mammalian Tissues

Published on: January 10, 2019

18.4K
Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets
06:40

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets

Published on: February 23, 2024

1.2K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

616

Area of Science:

  • Bioinformatics
  • Computational Biology
  • Genomics

Background:

  • Accurate sample classification via transcriptomics is vital for personalized medicine.
  • Existing sample size calculation methods may not suit machine learning (ML) for sample classification.
  • A methodological gap exists in determining optimal sample sizes for ML-based transcriptomics analyses.

Purpose of the Study:

  • To present a novel computational approach for establishing the accuracy-versus-sample size relationship in transcriptomics data.
  • To address the need for appropriate sample size determination in ML-driven transcriptomics studies.
  • To facilitate the development of clinically useful classifiers for personalized treatment.

Main Methods:

  • A novel computational approach using data augmentation and learning curve fitting.
  • Comprehensive performance evaluation on microRNA and RNA sequencing data.
  • Consideration of diverse data characteristics and algorithm configurations.

Main Results:

  • The developed approach effectively establishes the accuracy-sample size relationship for transcriptomics data.
  • Performance was validated across various data types and ML algorithms.
  • The method provides a robust framework for sample size estimation.

Conclusions:

  • The novel computational approach enhances the adoption of ML in transcriptomics.
  • This method accelerates the translation of transcriptomics findings into clinical applications.
  • Accessible code (Python, R) is provided to promote reproducibility and implementation.